The most useful question about altRx is not simply whether its advertised monthly price fits your budget. It is what happens after you submit an assessment: who evaluates you, what medicine they might prescribe, which pharmacy fills it and what you owe if treatment does not proceed. Its public documentation describes a telehealth weight-management membership connecting patients with OpenLoop-affiliated clinical practices and independent pharmacies. That division of responsibility matters when a question involves your prescription rather than your account.
This documentary review examines pages consulted October 19, 2026, with an emphasis on questions adults in the United States can resolve before paying. altRx publishes concrete prices and service details, alongside consequential limits and inconsistencies. The clearest examples are different cancellation notice periods and restrictions on refunds. Our starting questions for a GLP-1 program offer a broader checklist; here, the focus is on what altRx itself documents, what remains uncertain and which answers would make its offer easier to evaluate.
At a glance
- Advertised medication prices
- Product pages display $89/month for compounded GLP-1 and $149/month for compounded GLP-1/GIP, each identified as prescription-only and supplied in a multi-dose vial.
- Clinical responsibility
- Medical evaluation and prescribing are attributed to OpenLoop Healthcare Partners, PC and affiliated professional practices; altRx describes its own role as nonclinical.
- Cancellation conflict
- The cancellation policy requires at least 72 hours before the next billing date, while the terms describe cancellation up to 48 hours before monthly processing.
- Insurance restrictions
- altRx calls the membership self-pay; its terms also prohibit seeking or receiving reimbursement from federal, state or private healthcare payors for services or products provided through the service.
Who is responsible for your care?
Start by separating the brand taking your enrollment from the professionals making medical decisions. The terms say altRx provides marketing, customer support, informational content and administrative services; OpenLoop operates the platform; independent licensed professionals provide healthcare. A separate disclosure identifies OpenLoop Healthcare Partners, PC and affiliated practices as responsible for evaluation and prescribing. altRx expressly says it is not a medical group, pharmacy or healthcare provider. Ask which clinical practice will hold your records and how to contact it directly.
That legal description should carry more weight in your preparation than language suggesting a single integrated care team. There is also a corporate-name inconsistency: a safety page identifies Altrx, Inc., while the terms’ copyright-notification section names altRx LLC at the same Boca Raton address. This does not establish that care is unavailable or improper. It does make the practical question worthwhile: which entity appears on your payment receipt, membership agreement and clinical consent?
Privacy deserves a separate question before you enter health details. altRx states that it is not itself a HIPAA covered entity, while a HIPAA notice describes rights to inspect and copy medical and billing records and request corrections. Its consumer-health-data policy also allows sharing health data with third-party providers for advertising and marketing. Ask which policy governs your intake information, which organization maintains the medical record and how to exercise the relevant access or correction rights.
What does the advertised monthly price actually buy?
altRx documents compounded semaglutide and compounded tirzepatide as potential injectable treatments. Its corresponding compounded GLP-1 and GLP-1/GIP product pages display $89/month and $149/month, respectively, with prescription-only multi-dose vials. Safety pages describe both medicines as subcutaneous injections. These are concrete advertised prices, not merely unspecified starting estimates. However, the documentation does not establish the quantity in each shipment, total multi-month package charges or whether the advertised monthly rate requires a particular commitment.
The membership description includes telehealth consultations, a personalized care plan, prescription fulfillment when appropriate and shipping. The compounded GLP-1 page also advertises syringes, needles and alcohol swabs in the kit. The homepage says there are no membership fees and no price increases, although the service is structured as a subscription. Ask for a checkout summary distinguishing the recurring treatment charge from any separate charges and identifying the exact billing interval. A monthly display alone does not establish shipment quantity.
For readers preparing a budget, the unresolved items are specific: mandatory laboratory requirements and charges, terms of the advertised flexible payment options, and prices for branded medicines. Zepbound, Wegovy and Ozempic appear on the homepage as injectable options, but their presence does not establish your access or price. Use our questions beyond the monthly price to request a written breakdown rather than assuming every listed treatment is covered by the compounded-medication offer.
What happens between the free assessment and a prescription?
The advertised starting point is a free, approximately two-minute assessment with no obligation. It asks for height, weight and a target weight, and says the information helps calculate BMI and build a treatment profile. Completing that form does not itself create a provider-patient relationship with altRx. A licensed professional then reviews the health evaluation and conducts a telehealth consultation, potentially by live video or asynchronous review depending on the professional and applicable state telehealth requirements.
A prescription is expressly not guaranteed, and the professional retains prescribing discretion. Membership requires adulthood, and the platform says it does not prescribe GLP-1 medications to people under 18. Separately, its compounded-semaglutide safety page says that treatment is not for people 75 or older. That is a documented restriction on that page, not evidence of a universal age limit across every treatment altRx lists. Ask how the relevant product restrictions apply before purchasing a plan.
The provider says evaluation includes medical history, current medicines and contraindications, specifically mentioning personal or family history of medullary thyroid carcinoma and MEN2. Its complete initiation BMI criteria and mandatory laboratory requirements are not established in the consulted documentation. NIDDK advises discussing medicines, supplements, allergies and pregnancy plans with a clinician. Bring those details to the consultation rather than treating the website’s BMI calculation as an eligibility decision. Also ask when payment occurs relative to clinical review and how a denial affects charges.
Which medicine and pharmacy would you actually receive?
A useful next step is to ask for the exact prescribed formulation and dispensing pharmacy, not just the medicine family. altRx says it does not manufacture or compound medications and describes its compounding partners as independently owned, state-licensed 503A pharmacies. Its published network includes RedRock Pharmacy in St. George, Utah; Health Warehouse in Florence, Kentucky; Precision Medicine in Bellmore, New York; and Triad Rx in Daphne, Alabama. The documentation does not identify which pharmacy would serve a particular patient.
The terms permit a prescription to be sent to a pharmacy of your choice. That flexibility does not establish that an outside pharmacy will have the medicine or that altRx’s advertised package price will apply there. Ask whether changing pharmacies changes fulfillment, shipping or payment arrangements. The product page’s claims about USP 797 standards and purity and potency testing are provider statements; this review did not independently verify licenses, testing records or batch documentation.
altRx acknowledges that its compounded preparations are not FDA approved or independently evaluated by FDA for safety, efficacy or quality. FDA recommends compounded drugs when an individual’s medical needs cannot be met by an approved drug, with a prescription and a state-licensed pharmacy. Nonapproval alone does not prove clinical inequivalence. It also does not establish equivalence to an approved product. The practical question is why the proposed preparation fits your medical needs and what product-specific information the prescriber and pharmacist can provide.
What should you confirm before the next charge?
Recurring billing is one of the most important parts of this offer to clarify in writing. The terms authorize automatic charges at intervals disclosed during checkout until cancellation. Yet the cancellation documents do not agree: the dedicated policy requires requests at least 72 hours before the next billing date, while the terms describe cancellation up to 48 hours before monthly processing. Rather than assuming the shorter deadline controls, ask altRx to identify the applicable deadline and record the next billing date.
The dedicated policy says a request received inside its 72-hour window results in another nonrefundable cycle, with cancellation effective for the subsequent cycle. The terms identify care@altrx.com and the platform as cancellation routes. Multi-month plans have a separate material condition: the policy describes a full-term commitment exchanged for a discounted bundled rate, without prorating unused months, services or even unshipped medication. The documentation does not establish the package totals or whether a displayed monthly price belongs to such a plan.
Cancellation stops future billing; it does not itself return money already paid. Failure to finish intake, attend or complete a consultation, or accept or fill a prescription generally does not qualify for a refund. The medical-ineligibility exception provides a refund of the unused portion of the current term after subtracting services already delivered, such as consultations or reviews. Our questions to settle before renewal can help organize a written request covering timing, effective cancellation and any remaining commitment.
| Situation | Documented position | Question to ask |
|---|---|---|
| Routine renewal | Automatic charges at checkout-disclosed intervals | What is my exact next charge date and amount? |
| Cancellation notice | 72 hours in the policy; 48 hours in the terms | Which deadline applies to my purchase? |
| Multi-month purchase | Full-term commitment; no prorating of unused portions | What total am I buying and when is it collected? |
| Clinical ineligibility | Unused current-term portion refunded after service deductions | Which completed services will be deducted? |
| Incomplete onboarding | Non-use generally does not create a refund right | When does paid service begin? |
Who answers when treatment or delivery needs attention?
altRx advertises 24/7 access and unlimited appointments, messaging and support, but those statements do not establish an immediate clinical response. Its contact page calls the patient portal the fastest route for account, prescription or health questions. For general nonurgent inquiries, it asks readers to allow up to 48 hours and lists +1 607-601-6969. Before enrolling, ask how a clinical question is routed, who answers it and what response interval applies outside ordinary hours.
After a professional determines treatment is appropriate, the FAQ estimates approximately 4–5 business days for processing and delivery together. It is not a separate guarantee for the initial clinical review. The terms also warn that pharmacy processing, verification, carriers, weather and holidays can affect shipping. For damaged items, the policy allows pharmacy replacement after evidence of damage; incorrect items are also replaced. Replacement is described as the sole remedy, with no refund for either category.
Temperature concerns require more than an ordinary customer-service ticket. FDA explicitly recommends not using an injectable GLP-1 drug that arrives warm or with insufficient refrigeration and contacting the provider or dispensing pharmacy. Ask ahead of time whom to contact and what documentation the pharmacy needs. For multi-dose vials, FDA also reports measuring and administration errors with compounded medications; instructions should be clarified with the prescriber or pharmacist rather than worked out from an online review.
Do geography and insurance change the offer?
The terms advertise service only within the United States, covering all 50 states and the District of Columbia. Another disclosure says professional availability and prescribing authority vary by state and that the assigned professional will be licensed in the patient’s state of residence. These statements describe intended reach, not guaranteed appointment availability or an individual prescription. Confirm the clinical practice, consultation format and pharmacy options available for your location before assuming the national offer applies unchanged.
The FAQ calls altRx a self-pay healthcare service that does not require insurance. The terms go further: neither the patient nor participating entities may seek or receive reimbursement from federal, state or private healthcare payors for products or services obtained through the service. That distinction matters if you expect to pay first and submit a claim afterward. This is not simply a statement that altRx will decline to handle insurance paperwork on your behalf.
Flexible payment options are mentioned without detailed terms in the consulted documentation. Likewise, advertised HSA/FSA messaging does not establish eligibility, required receipts or the payment process for your purchase. Ask for those details without assuming account eligibility or a tax result. No confirmed Spanish-language clinical service, interpretation arrangement or Spanish contractual documentation was established either. If language access is important, verify it for both the clinical consultation and pharmacy instructions, not only general customer support.
What will follow-up establish beyond continued access?
The membership promises a personalized care plan and access to consultations, but useful follow-up should be distinguishable from the next payment. Ask how reviews are scheduled, how symptoms and progress are assessed, and which professional decides whether treatment continues. altRx specifically addresses BMI falling below 25: the clinician will reassess and may adjust treatment, move to maintenance or pause or discontinue depending on goals and risk factors. It does not promise automatic continuation once a weight target is reached.
Evidence questions should remain equally specific. Published trials of semaglutide and tirzepatide are not studies of altRx’s membership or its compounded preparations, and cannot establish an individual’s result. The provider’s acknowledgment of nonapproval is important context when reading product marketing. Our questions about advertised weight-loss evidence help distinguish a medicine’s research literature from measured outcomes for the exact formulation and service being offered. Ask which claim is supported by which kind of evidence.
NIDDK describes obesity as a chronic disease that may require long-term care, with duration depending on response and side effects. That makes transition planning a practical enrollment question: what happens if treatment is paused, the clinician recommends stopping or you leave the membership? altRx’s consulted documentation does not explain a membership pause’s effect on charges, shipments or renewal. Obtain those operational answers separately from medical advice, and do not assume that stopping payments guarantees maintained results or a continuing care relationship.
Questions & answers
Is altRx itself the medical provider?
Its terms say no. altRx describes nonclinical administrative, marketing and support functions. Medical evaluation and prescribing are attributed to OpenLoop Healthcare Partners, PC and affiliated practices. Ask for your assigned practice’s name and direct clinical contact, rather than assuming an altRx customer-service representative is responsible for medical decisions.
Are $89 and $149 the documented monthly prices?
Yes. The compounded GLP-1 product page displays $89/month, and the compounded GLP-1/GIP page displays $149/month, both for prescription-only multi-dose vials. What is not established is the shipment quantity, total multi-month package price or commitment attached to those monthly displays. Request the complete checkout terms before treating either figure as your entire obligation.
Does the free assessment guarantee medication?
No. The assessment is advertised as free and without obligation, but a licensed professional must evaluate medical appropriateness before prescribing. The professional retains sole discretion, and altRx expressly says a prescription is never guaranteed. Completing the website assessment also does not itself create a provider-patient relationship with altRx.
Can I cancel the day before renewal?
Do not assume that would prevent another charge. The dedicated policy requires at least 72 hours’ notice, while the terms describe 48 hours before monthly processing. The policy says requests inside its window trigger another nonrefundable cycle. Ask altRx to reconcile the deadlines in writing and confirm receipt and the effective cancellation date.
What if a clinician decides I am not eligible?
The policy provides cancellation and a refund for the unused portion of the current term, minus services already rendered, including consultations or professional reviews. It does not promise every dollar back. Ask which services have been delivered and how the deduction is calculated; ordinary cancellation or incomplete onboarding does not carry the same refund exception.
Can I choose a pharmacy outside the altRx network?
The terms allow an issued prescription to be sent to a pharmacy of your choice. They do not establish that an outside pharmacy can fill it or that the advertised membership price transfers unchanged. Confirm availability, payment and shipping arrangements before requesting a transfer, and identify who will handle any prescription clarification.
Our assessment
altRx provides useful starting information: published compounded-medication prices, named clinical and pharmacy relationships, a defined intake process and specific support channels. Its documentation is less settled where a patient needs a dependable financial commitment: the cancellation deadlines conflict, multi-month purchases carry restrictive refund terms, and monthly advertising does not establish package totals or shipment quantities. A practical next step is a written confirmation of the exact product, dispensing pharmacy, full purchase obligation, renewal date and applicable cancellation deadline before payment. Separately, ask the treating professional why the proposed medication fits your medical needs and how follow-up will work. Those answers would make the service more assessable; the public documentation alone does not establish treatment suitability, independently verified product quality or an individual outcome.
This opens the reviewed business’s website. The link is not a prescription or endorsement. Commercial relationships.
Sources & documentation
Public materials consulted October 19, 2026. Provider statements are attributed claims, not independently verified clinical outcomes. Terms can change; obtain a current written quote.
- FDA concerns with unapproved GLP-1 drugs used for weight loss ↗
- NIDDK: prescription medications for overweight and obesity ↗
- Wilding et al. (2021): STEP 1 semaglutide trial ↗
- Jastreboff et al. (2022): SURMOUNT-1 tirzepatide trial ↗
- altRx — products/compounded semaglutide ↗
- altRx — v3/consultation ↗
- altRx — about ↗
- altRx — v3/terms and conditions ↗
- altRx — contact ↗
- altRx — important safety information/compounded tirzepatide ↗
- altRx — v3/consumer health data privacy policy ↗
- altRx — important safety information/compounded semaglutide ↗
- altRx — official website ↗
- altRx — v3/privacy practices ↗
- altRx — v3/refund cancellation policy ↗
- altRx — products/compounded tirzepatide ↗